These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30157383)

  • 1. Bacteriophage for Gastrointestinal Health (PHAGE) Study: Evaluating the Safety and Tolerability of Supplemental Bacteriophage Consumption.
    Gindin M; Febvre HP; Rao S; Wallace TC; Weir TL
    J Am Coll Nutr; 2019 Jan; 38(1):68-75. PubMed ID: 30157383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHAGE Study: Effects of Supplemental Bacteriophage Intake on Inflammation and Gut Microbiota in Healthy Adults.
    Febvre HP; Rao S; Gindin M; Goodwin NDM; Finer E; Vivanco JS; Lu S; Manter DK; Wallace TC; Weir TL
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30897686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PHAGE-2 Study: Supplemental Bacteriophages Extend
    Grubb DS; Wrigley SD; Freedman KE; Wei Y; Vazquez AR; Trotter RE; Wallace TC; Johnson SA; Weir TL
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally-occurring and cultured bacteriophages in human therapy.
    Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial.
    Leitner L; Sybesma W; Chanishvili N; Goderdzishvili M; Chkhotua A; Ujmajuridze A; Schneider MP; Sartori A; Mehnert U; Bachmann LM; Kessler TM
    BMC Urol; 2017 Sep; 17(1):90. PubMed ID: 28950849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.
    Rostok M; Hütt P; Rööp T; Smidt I; Štšepetova J; Salumets A; Mändar R
    Benef Microbes; 2019 Apr; 10(4):385-393. PubMed ID: 30882242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: bacteriophages in gastroenterology-from biology to clinical applications.
    Sabino J; Hirten RP; Colombel JF
    Aliment Pharmacol Ther; 2020 Jan; 51(1):53-63. PubMed ID: 31696976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The varying effects of a range of preservatives on Myoviridae and Siphoviridae bacteriophages formulated in a semi-solid cream preparation.
    Brown TL; Ku H; Mnatzaganian G; Angove M; Petrovski S; Kabwe M; Tucci J
    Lett Appl Microbiol; 2020 Aug; 71(2):203-209. PubMed ID: 32294268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of bacteriophage therapy in severe Staphylococcus aureus infection.
    Petrovic Fabijan A; Lin RCY; Ho J; Maddocks S; Ben Zakour NL; Iredell JR;
    Nat Microbiol; 2020 Mar; 5(3):465-472. PubMed ID: 32066959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering phage therapy per os: benefits and barriers.
    Zelasko S; Gorski A; Dabrowska K
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):167-179. PubMed ID: 27885865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthy human gut phageome.
    Manrique P; Bolduc B; Walk ST; van der Oost J; de Vos WM; Young MJ
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):10400-5. PubMed ID: 27573828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
    Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
    Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial.
    François IE; Lescroart O; Veraverbeke WS; Marzorati M; Possemiers S; Evenepoel P; Hamer H; Houben E; Windey K; Welling GW; Delcour JA; Courtin CM; Verbeke K; Broekaert WF
    Br J Nutr; 2012 Dec; 108(12):2229-42. PubMed ID: 22370444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophages of the Urinary Microbiome.
    Miller-Ensminger T; Garretto A; Brenner J; Thomas-White K; Zambom A; Wolfe AJ; Putonti C
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29378882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Edible Cricket Consumption on Gut Microbiota in Healthy Adults, a Double-blind, Randomized Crossover Trial.
    Stull VJ; Finer E; Bergmans RS; Febvre HP; Longhurst C; Manter DK; Patz JA; Weir TL
    Sci Rep; 2018 Jul; 8(1):10762. PubMed ID: 30018370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy.
    Javaudin F; Latour C; Debarbieux L; Lamy-Besnier Q
    Clin Microbiol Rev; 2021 Dec; 34(4):e0013621. PubMed ID: 34668734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study.
    Culpepper T; Rowe CC; Rusch CT; Burns AM; Federico AP; Girard SA; Tompkins TA; Nieves C; Dennis-Wall JC; Christman MC; Langkamp-Henken B
    Benef Microbes; 2019 May; 10(5):497-509. PubMed ID: 31090458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
    Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
    Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.